First, DSIP's short half-life means timing and route strongly affect any potential effect
In a drug safety update, published on 28 January 2025, the MHRA cited findings of a recent European Medicines Agency (EMA) review of the available evidence for all GLP-1 and dual GIP/GLP-1 RAs, which concluded that data supports an association between the medicines and the potential risk of pulmonary aspiration during anaesthesia or deep sedation, owing to the delayed gastric emptying linked to these medicines
Most of the time, these symptoms are mild to moderate and improve as your body adjusts to the medication
While BPC-157 targets localized repair in muscles, tendons, and the gastrointestinal tract, TB-500 works systemically to promote cell migration, improve flexibility, and support new blood vessel formation throughout the body
When the medication becomes less potent, it may deliver a lower dose than intended, making treatment less effective